• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体包裹的胞壁酰二肽及其亲脂性类似物对人单核细胞杀伤肿瘤细胞的增强作用。

Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.

作者信息

Sone S, Mutsuura S, Ogawara M, Tsubura E

出版信息

J Immunol. 1984 Apr;132(4):2105-10.

PMID:6699409
Abstract

Human monocytes harvested from healthy donors and separated by discontinuous gradient centrifugation and adherence were highly cytotoxic to allogeneic melanoma cells, but did not affect nontumorigenic cells, as measured by lysis of the cells. After 4 days incubation of these monocytes in medium, they showed little, if any, cytolytic activity. Hydrophilic muramyl dipeptide (MDP) or lipophilic muramyl tripeptide (MTP-PE) was encapsulated within multilamellar (MLV) liposomes composed of phosphatidylserine-phosphatidylcholine. The cultured monocytes were rendered tumoricidal by interaction for 24 hr with MDP or liposomes containing soluble MDP or lipophilic MTP-PE. Moreover, freshly isolated monocytes treated for 24 hr with liposomes containing MDP or MTP-PE remained tumoricidal during culture for up to 5 days. About 1,600-times lower concentration of MDP entrapped in liposomes than of free MDP in the medium was effective for rendering monocytes tumoricidal. Similarly, about 80-times lower concentration of MTP-PE in liposomes than of free MDP was effective for the activation of monocytes. It is concluded that MLV liposomes containing MDP or MTP-PE are far more efficient in potentiating the tumoricidal activity of human monocytes than unencapsulated, free MDP.

摘要

从健康供体采集的人类单核细胞,通过不连续梯度离心和贴壁分离后,对同种异体黑色素瘤细胞具有高度细胞毒性,但对非致瘤细胞没有影响,这通过细胞裂解来衡量。这些单核细胞在培养基中孵育4天后,几乎没有(如果有的话)细胞溶解活性。亲水性胞壁酰二肽(MDP)或亲脂性胞壁酰三肽(MTP-PE)被包裹在由磷脂酰丝氨酸-磷脂酰胆碱组成的多层脂质体(MLV)中。培养的单核细胞通过与MDP或含有可溶性MDP或亲脂性MTP-PE的脂质体相互作用24小时而具有杀肿瘤活性。此外,用含有MDP或MTP-PE的脂质体处理24小时的新鲜分离单核细胞在培养长达5天期间仍具有杀肿瘤活性。脂质体中包裹的MDP浓度比培养基中游离MDP浓度低约1600倍时,对使单核细胞具有杀肿瘤活性有效。同样,脂质体中MTP-PE浓度比游离MDP低约80倍时,对单核细胞的激活有效。得出的结论是,含有MDP或MTP-PE的MLV脂质体在增强人类单核细胞的杀肿瘤活性方面比未包裹的游离MDP效率高得多。

相似文献

1
Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.脂质体包裹的胞壁酰二肽及其亲脂性类似物对人单核细胞杀伤肿瘤细胞的增强作用。
J Immunol. 1984 Apr;132(4):2105-10.
2
Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.含亲脂性胞壁酰三肽的脂质体激活人血单核细胞的杀肿瘤特性。
Cancer Res. 1983 May;43(5):2010-4.
3
Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).含新型亲脂性胞壁酰肽衍生物MDP-L-丙氨酰-胆固醇(MTP-CHOL)的脂质体在体外激活巨噬细胞的抑制细胞生长和细胞毒性活性。
J Biol Response Mod. 1985 Oct;4(5):464-74.
4
Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.人肺泡巨噬细胞:脂质体包裹的胞壁酰二肽增强其杀肿瘤活性。
J Immunol. 1982 Sep;129(3):1313-7.
5
Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.含有胞壁酰二肽的脂质体对增强人肺泡巨噬细胞杀肿瘤活性的潜在价值。
J Biol Response Mod. 1984;3(2):185-94.
6
Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.游离的和脂质体包裹的(3H标记的)去甲胞壁酰二肽或胞壁酰三肽磷脂酰乙醇胺与人血单核细胞的比较相互作用。
Int J Immunopharmacol. 1987;9(2):141-50. doi: 10.1016/0192-0561(87)90088-9.
7
Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.含有新型亲脂性胞壁酰二肽衍生物的冻干脂质体激活肺泡巨噬细胞的杀肿瘤活性并消除实验性转移灶。
Cancer Res. 1985 Jan;45(1):128-34.
8
Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.人重组γ干扰素与包裹在脂质体中的胞壁酰二肽之间的协同作用,用于激活人血单核细胞的抗肿瘤特性。
Cancer Res. 1985 Dec;45(12 Pt 1):6188-93.
9
[Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].[γ干扰素与脂质体包裹的胞壁酰三肽协同作用诱导人单核细胞的杀肿瘤特性]
Gan To Kagaku Ryoho. 1986 Oct;13(11):3161-8.
10
Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.脂质体包裹的重组小鼠或人γ干扰素对巨噬细胞杀肿瘤特性激活的种属特异性消除。
J Immunol. 1985 Dec;135(6):4289-96.

引用本文的文献

1
Highlights into historical and current immune interventions for cancer.癌症免疫治疗的历史和现状概述。
Int Immunopharmacol. 2023 Apr;117:109882. doi: 10.1016/j.intimp.2023.109882. Epub 2023 Feb 27.
2
Carbohydrate-based drugs launched during 20002021.2000年至2021年期间推出的碳水化合物类药物。 (你提供的原文“20002021”表述有误,推测应该是“2000 - 2021” )
Acta Pharm Sin B. 2022 Oct;12(10):3783-3821. doi: 10.1016/j.apsb.2022.05.020. Epub 2022 May 23.
3
Identification of a 7-mRNA signature as a prognostic biomarker in pediatric osteosarcoma.
鉴定一种7-mRNA特征作为小儿骨肉瘤的预后生物标志物。
Transl Cancer Res. 2020 Nov;9(11):6733-6742. doi: 10.21037/tcr-20-2407.
4
Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy.骨肉瘤免疫微环境中的巨噬细胞:对免疫治疗的启示
Front Oncol. 2020 Dec 10;10:586580. doi: 10.3389/fonc.2020.586580. eCollection 2020.
5
Adamantane Containing Peptidoglycan Fragments Enhance RANTES and IL-6 Production in Lipopolysaccharide-Induced Macrophages.含金刚烷的肽聚糖片段增强脂多糖诱导的巨噬细胞中 RANTES 和 IL-6 的产生。
Molecules. 2020 Aug 14;25(16):3707. doi: 10.3390/molecules25163707.
6
Translation of peptidoglycan metabolites into immunotherapeutics.将肽聚糖代谢产物转化为免疫疗法。
Clin Transl Immunology. 2019 Nov 29;8(12):e1095. doi: 10.1002/cti2.1095. eCollection 2019.
7
High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation.高浓度的脂质偶联 TLR7 激动剂需要纳米颗粒或脂质体制剂。
Eur J Pharm Sci. 2018 Oct 15;123:268-276. doi: 10.1016/j.ejps.2018.07.048. Epub 2018 Jul 24.
8
Managing sarcoma: where have we come from and where are we going?肉瘤的管理:我们从何而来,又将走向何方?
Ther Adv Med Oncol. 2017 Oct;9(10):637-659. doi: 10.1177/1758834017728927. Epub 2017 Sep 20.
9
Translational biology of osteosarcoma.骨肉瘤的转化生物学。
Nat Rev Cancer. 2014 Nov;14(11):722-35. doi: 10.1038/nrc3838. Epub 2014 Oct 16.
10
Review of mifamurtide in the treatment of patients with osteosarcoma.米伐木肽治疗骨肉瘤患者的研究综述。
Ther Clin Risk Manag. 2010 Jun 24;6:279-86. doi: 10.2147/tcrm.s5688.